Nucleic Acid Therapeutics in an Age of Artificial Intelligence.

IF 4.5 2区医学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY

Nucleic acid therapeutics Pub Date : 2026-12-01 Epub Date: 2026-10-15 DOI:10.1177/21593337261496161

David R Corey

引用次数: 0

Abstract

Artificial intelligence (AI) is transforming how scientific hypotheses are formulated, tested, and applied. Nucleic acid therapeutics can benefit from emerging opportunities but will also face new challenges. AI lowers the barrier to hypothesis generation, increasing the emphasis on critical evaluation, rigorous experimental testing, and expert judgement. The goal of this perspective is to begin that discussion, with an emphasis on basic and applied research at the interface of nucleic acid science and medicine.

查看原文本刊更多论文

人工智能时代的核酸疗法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Nucleic acid therapeutics BIOCHEMISTRY & MOLECULAR BIOLOGY-CHEMISTRY, MEDICINAL

CiteScore

7.60

自引率

7.50%

发文量

审稿时长

>12 weeks

期刊介绍： Nucleic Acid Therapeutics is the leading journal in its field focusing on cutting-edge basic research, therapeutic applications, and drug development using nucleic acids or related compounds to alter gene expression. The Journal examines many new approaches for using nucleic acids as therapeutic agents or in modifying nucleic acids for therapeutic purposes including: oligonucleotides, gene modification, aptamers, RNA nanoparticles, and ribozymes.